Central nervous system involvement in systemic lupus erythematosus: An imaging challenge

Israel Medical Association Journal

Volumn 15, Issue 7, 2013, Pages 382-386

  Yaniv, Gal ^a   Twig, Gilad ^a   Mozes, Oshry ^a   Greenberg, Gahl ^a   Hoffmann, Chen ^a   Shoenfeld, Yehuda ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Computed tomography (CT); Diffuse tensor imaging (DTI); Diffusion weighted imaging (DWI); Magnetic resonance imaging (MRI); Neuropsychiatric systemic lupus erythematosus (NPSLE); Systemic lupus erythematosus (SLE)

Indexed keywords

CARDIOLIPIN ANTIBODY; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; N ACETYLASPARTIC ACID;

BRAIN ATROPHY; BRAIN DAMAGE; BRAIN EDEMA; CALCIFICATION; CENTRAL NERVOUS SYSTEM; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

CENTRAL NERVOUS SYSTEM; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE SPECTROSCOPY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;

EID: 84881508665     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42 (4): 599-608.
2. Hanly JG, Harrison MJ. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol 2005; 19 (5): 799-821.
3. Peterson PL, Axford JS, Isenberg D. Imaging in CNS lupus. Best Pract Res Clin Rheumatol 2005; 19 (5): 727-39.
4. Borchers AT, Aoki CA, Naguwa SM, Keen CL, Shoenfeld Y, Gershwin ME. Neuropsychiatric features of systemic lupus erythematosus. Autoimmun Rev 2005; 4 (6): 329-44.
5. Sanna G, Piga M, Terryberry JW, et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000; 9 (8): 573-83.
6. Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999; 42 (10): 2026-38.
7. Huizinga TW, Steens SC, van Buchem MA. Imaging modalities in central nervous system systemic lupus erythematosus. Curr Opin Rheumatol 2001; 13 (5): 383-8.
8. Appenzeller S, Pike GB, Clarke AE. Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol 2008; 34 (3): 361-6.
9. Castellino G, Govoni M, Giacuzzo S, Trotta F. Optimizing clinical monitoring of central nervous system involvement in SLE. Autoimmun Rev 2008; 7 (4): 297-304.
10. Katsumata Y, Harigai M, Kawaguchi Y, et al. Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study. BMC Musculoskelet Disord 2010; 11: 13.
11. Lopez-Longo FJ, Carol N, Almoguera MI, et al. Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage. Lupus 2003; 12 (11): 813-19.
12. Sun SS, Liu FY, Tsai JJ, Yen RF, Kao CH, Huang WS. Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement - a preliminary report. Rheumatol Int 2003; 23 (6): 301-4.
13. Colamussi P, Giganti M, Cittanti C, et al. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 1995; 22 (1): 17-24.
14. Weiner SM, Otte A, Schumacher M, et al. Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus. Lupus 2000; 9 (5): 386-9.
15. Fitzgibbon BM, Fairhall SL, Kirk IJ, et al. Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls. Rheumatology (Oxford) 2008; 47 (1): 50-3.
16. Mackay M, Bussa MP, Aranow C, et al. Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration. Mol Med 2011; 17 (11-12): 1349-56.
17. Baum KA, Hopf U, Nehrig C, Stover M, Schorner W. Systemic lupus erythematosus: neuropsychiatric signs and symptoms related to cerebral MRI findings. Clin Neurol Neurosurg 1993; 95 (1): 29-34.
18. McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988; 31 (2): 159-66.
19. Sibbitt WL, Jr., Sibbitt RR, Griffey RH, Eckel C, Bankhurst AD. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 1989; 48 (12): 1014-22.
20. Cauli A, Montaldo C, Peltz MT, et al. Abnormalities of magnetic resonance imaging of the central nervous system in patients with systemic lupus erythematosus correlate with disease severity. Clin Rheumatol 1994; 13 (4): 615-18.
21. Gonzalez-Crespo MR, Blanco FJ, Ramos A, et al. Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatol 1995; 34 (11): 1055-60.
22. Hachulla E, Michon-Pasturel U, Leys D, et al. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus 1998; 7 (2): 124-31.
23. Jacobs L, Kinkel PR, Costello PB, Alukal MK, Kinkel WR, Green FA. Central nervous system lupus erythematosus: the value of magnetic resonance imaging. J Rheumatol 1988; 15 (4): 601-6.
24. Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P. Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 2004; 46 (1): 15-21.
25. Karassa FB, Ioannidis JP, Boki KA, et al. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 2000; 109 (8): 628-34.
26. Graham JW, Jan W. MRI and the brain in systemic lupus erythematosus. Lupus 2003; 12 (12): 891-6.
27. Csepany T, Bereczki D, Kollar J, Sikula J, Kiss E, Csiba L. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension. J Neurol 2003; 250 (11): 1348-54.
28. Zandman-Goddard G, Chapman J, Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 2007; 36 (5): 297-315.
29. Kumral E, Evyapan D, Keser G, et al. Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus. Eur Neurol 2002; 47 (3): 131-5.
30. Sanna G, D'Cruz D, Cuadrado MJ. Cerebral manifestations in the antiphospholipid (Hughes) syndrome. Rheum Dis Clin North Am 2006; 32 (3): 465-90.
31. Bosma GP, Huizinga TW, Mooijaart SP, Van Buchem MA. Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol 2003; 24 (5): 850-4.
32. Axford JS, Howe FA, Heron C, Griffiths JR. Sensitivity of quantitative (1) H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus. Ann Rheum Dis 2001; 60 (2): 106-11.
33. Welsh RC, Rahbar H, Foerster B, Thurnher M, Sundgren PC. Brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus with new acute neurological symptoms. J Magn Reson Imaging 2007; 26 (3): 541-51.
34. Jung RE, Caprihan A, Chavez RS, et al. Diffusion tensor imaging in neuropsychiatric systemic lupus erythematosus. BMC Neurol 2010; 10: 65.
35. Zhang L, Harrison M, Heier LA, et al. Diffusion changes in patients with systemic lupus erythematosus. Magn Reson Imaging 2007; 25 (3): 399-405.
36. Hughes M, Sundgren PC, Fan X, et al. Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain. Acta Radiol 2007; 48 (2): 213-22.
37. Friedman SD, Stidley CA, Brooks WM, Hart BL, Sibbitt WL Jr. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology 1998; 209 (1): 79-84.
38. Lim MK, Suh CH, Kim HJ, et al. Systemic lupus erythematosus: brain MR imaging and single-voxel hydrogen 1 MR spectroscopy. Radiology 2000; 217 (1): 43-9.
39. Vermathen P, Ende G, Laxer KD, et al. Temporal lobectomy for epilepsy: recovery of the contralateral hippocampus measured by (1)H MRS. Neurology 2002; 59 (4): 633-6.
40. Brooks WM, Sabet A, Sibbitt WL Jr, et al. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 1997; 24 (12): 2323-9.